Heidi Flanagan v. HHS - Influenza, Guillain-Barre syndrome (GBS) (2025)
Case summary [AI summaries can sometimes make mistakes]
On March 7, 2023, Heidi Flanagan filed a petition alleging that an influenza vaccine administered on October 26, 2021 caused Guillain-Barre syndrome. The public materials show she filed for herself as an adult; they do not state an exact age.
Respondent conceded entitlement, agreeing that Ms. Flanagan's illness met the Table criteria for GBS because onset occurred within the 3-to-42-day interval and no apparent alternative cause was identified.
The damages record described ascending paresthesias beginning around November 5, 2021. By November 30, 2021, a neurologist documented absent deep tendon reflexes bilaterally, weak hip flexors, a wide-based unsteady gait, and concern for GBS.
She was sent to the emergency department for MRI imaging, lumbar puncture, IVIG, and electrodiagnostic workup. Ms.
Flanagan's course was described as unusually mild compared with many GBS cases, but still disruptive. She was hospitalized for three days, received five IVIG infusions, endured a difficult lumbar puncture and painful EMG, and was separated from her newborn while breastfeeding.
She later reported rare residual tingling but no further GBS treatment. On October 31, 2025, Chief Special Master Corcoran awarded $135,000.00 for pain and suffering.
Theory of causation
Influenza vaccine October 26, 2021 causing Table GBS in adult petitioner. COMPENSATED. Onset around November 5, 2021 (10 days): ascending paresthesias; by November 30, 2021 absent DTRs, weak hip flexors, wide-based unsteady gait, and neurologist-directed ER workup. Treated with 3-day hospitalization, 5 IVIG infusions, lumbar puncture, EMG; residual rare tingling. Respondent conceded Table GBS/no apparent alternative. Entitlement December 11, 2023; damages October 31, 2025. Award $135,000 pain/suffering. Petition filed March 7, 2023.
Source PDFs
USCOURTS-cofc-1_23-vv-00328